Theory Paper IDrNB Cardiology – Theory Notes

VSD DEVICE CLOSURE: CURRENT STATUS

2-page exam answerLast reviewed: October 2026
Merit MedScript seal

IANATOMICAL SUITABILITY

  • Muscular VSD: Ideal for device closure due to being surrounded by a thick muscular rim. Most common indication.
  • Perimembranous VSD (pmVSD): Technically feasible but controversial due to the proximity of the Tricuspid valve and the Bundle of His.
  • Doubly Committed Subarterial VSD: Generally not suitable for device closure as it lacks a superior rim and risks causing Aortic Valve prolapse/regurgitation.
  • Post-MI VSD: High-risk surgical patients. Device closure acts as a bridge to surgery or a primary therapy, though tissue fragility makes it challenging.

IIINDICATIONS FOR CLOSURE

  • Hemodynamic Significance: Left-to-right shunt with Qp:Qs ratio of 1.5 to 1 or higher.
  • Left Heart Overload: Progressive Left Atrial or Left Ventricular enlargement on echocardiography.
  • History of Endocarditis: Regardless of the shunt size.
  • Symptomatic Patients: Failure to thrive (infants), dyspnea, or reduced exercise tolerance.
  • Pulmonary Hypertension: Indicated if Pulmonary Vascular Resistance is less than 3 Wood Units.

IIIPROCEDURAL TECHNIQUES

  • Arteriovenous (AV) Loop: The standard technique. A wire is passed from the arterial side, through the VSD, into the venous system, and snared to create a stable rail for device delivery.
  • Imaging: Transesophageal Echocardiography (TEE) or Intracardiac Echocardiography (ICE) is used alongside fluoroscopy to guide placement.
  • Device Selection:
    • Amplatzer Muscular VSD Occluder: Double-disc nitinol device with a thick waist to match the muscular septum.
    • Amplatzer Membranous VSD Occluder: Specifically shaped to avoid interference with the heart valves.
    • Amplatzer Duct Occluder (ADO I / ADO II): Frequently used “off-label” for certain perimembranous defects to minimize conduction system pressure.

IVCOMPLICATIONS AND LIMITATIONS

  • Complete Heart Block (CHB): The most significant risk in perimembranous VSD closure (up to 5 percent). Can occur acutely or as a late complication due to mechanical compression of the AV node.
  • Tricuspid/Aortic Regurgitation: Caused by device interference with valve leaflets or subvalvular apparatus.
  • Device Embolization: Risk is higher in large defects with inadequate muscular rims.
  • Vascular Injury: Significant risk in small children due to the large sheath sizes required for the AV loop.
  • Hemolysis: High-velocity residual shunting through or around the device can cause mechanical red cell destruction.

VCURRENT EVIDENCE AND OUTCOMES

  • Muscular VSD: Device closure is the established gold standard with success rates exceeding 95 percent and minimal complications.
  • Perimembranous VSD: Remains a debated topic. While technically successful, the risk of permanent pacemaker implantation leads many centers to prefer surgery in young children.
  • Post-MI VSD: Early device closure is associated with high mortality due to necrotic tissue, but delayed closure (after 3 to 4 weeks) shows significantly better outcomes as the tissue becomes fibrotic.
meritmedscript.comDr. Sidhartha Mullapudi

Was this answer useful?

Your rating helps decide which topics to expand next.

Report an error

Spotted something outdated or incorrect? Tell us and we will check it against the source.